International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct

Rao, S, Sclafani, F, Eng, C et al. (18 more authors) (2020) International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct. Journal of Clinical Oncology, 38 (22). pp. 2510-2518. ISSN 0732-183X

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2020 by American Society of Clinical Oncology. Reproduced in accordance with the publisher's self-archiving policy.
Dates:
  • Accepted: 21 April 2020
  • Published (online): 12 June 2020
  • Published: 1 August 2020
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 10 Jul 2020 11:18
Last Modified: 12 Jun 2021 00:38
Status: Published
Publisher: American Society of Clinical Oncology
Identification Number: https://doi.org/10.1200/JCO.19.03266
Related URLs:

Export

Statistics